Quantbot Technologies LP Jounce Therapeutics, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.01 - $8.54 $3,371 - $4,790	-561 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.11 - $9.64 $3,555 - $4,820	-500 Reduced 47.13%	561 $4,000
Q3 2021 Nov 09, 2021	SELL	$5.04 - $8.73 $5,544 - $9,603	-1,100 Reduced 50.9%	1,061 $7,000
Q2 2021 Aug 12, 2021	BUY	$6.58 - $10.66 $11,844 - $19,188	1,800 Added 498.61%	2,161 $14,000
Q1 2021 May 14, 2021	BUY	$6.73 - $13.87 $2,429 - $5,007	361 New	361 $3,000
Q2 2018 Aug 13, 2018	SELL	$7.27 - $21.88 $20,799 - $62,598	-2,861 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$13.4 - $28.4 $38,337 - $81,252	2,861 New	2,861 $63,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.